vitamin d
18 interactions related to vitamin d
omega-3 + vitamin d
Fat from omega-3 supports absorption of the fat-soluble vitamin D
vitamin d + magnesium
Magnesium helps activate and support the function of vitamin D; low magnesium can reduce the effectiveness of vitamin D supplementation. This is a beneficial nutrient synergy rather than a harmful interaction.
vitamin d + vitamin k2
Vitamin D and vitamin K2 act synergistically on calcium metabolism: vitamin D increases calcium absorption while vitamin K2 activates osteocalcin and matrix Gla protein to direct calcium into bone and away from soft tissue. The main caution is for people taking warfarin.
caffeine + vitamin d
Higher caffeine intake is weakly associated with lower vitamin D status. In cell studies caffeine reduces vitamin D receptor (VDR) expression in bone-forming cells, and a large NHANES cross-sectional analysis links higher caffeine intake to a modestly greater chance of low serum 25-hydroxyvitamin D. The effect is small and matters most for people who already have low vitamin D, low calcium intake, and high bone-loss risk (for example, postmenopausal women). It is not an absorption-level interaction, so there is no need to separate the timing of a vitamin D supplement from coffee.
vitamin a + vitamin d
Vitamins A and D share the RXR receptor partner, but the best human evidence shows high-dose preformed vitamin A can blunt vitamin D's effect on calcium and bone; the relationship is competitive, not a proven beneficial synergy. At ordinary dietary or multivitamin levels there is no meaningful problem.
prednisone + vitamin d
Glucocorticoids such as prednisone speed up the breakdown of vitamin D and blunt vitamin D-driven calcium absorption at the gut, which contributes to bone loss. Population data link oral steroid use to a higher rate of severe vitamin D deficiency, so vitamin D plus adequate calcium is a standard part of long-term steroid care.
boron + magnesium
Boron appears to help the body retain magnesium by reducing how much is lost in the urine, and both minerals support the activation of vitamin D and healthy bone metabolism. The combined human evidence is modest and partly context-dependent, but the pairing is low-risk and biologically plausible, with the strongest rationale for postmenopausal bone health.
methylprednisolone + vitamin d
Methylprednisolone (a glucocorticoid) speeds the breakdown of vitamin D and weakens vitamin D-driven intestinal calcium absorption. Over continued therapy this lowers vitamin D status and contributes to glucocorticoid-induced bone loss.
hydrochlorothiazide + calcium
Thiazide diuretics such as hydrochlorothiazide increase the kidney's reabsorption of calcium and reduce how much calcium leaves the body in urine. This calcium-sparing effect is often beneficial, but combined with generous calcium supplements, high-dose vitamin D, or underlying parathyroid disease it can push blood calcium too high (hypercalcemia).
phenobarbital + vitamin d
Phenobarbital is a strong inducer of liver enzymes that speed the breakdown of vitamin D, so long-term use can lower 25-hydroxyvitamin D and, over months to years, contribute to softened bones (osteomalacia in adults, rickets in children) and higher fracture risk. Children and older or housebound adults are most vulnerable. The drop in vitamin D is well documented; some experimental work also suggests phenobarbital may slow vitamin D activation, though that mechanism rests on animal and cell studies. Have vitamin D and bone-related labs reviewed and discuss ongoing vitamin D with your doctor or pharmacist.
hydrochlorothiazide + vitamin d
Hydrochlorothiazide (HCTZ) lowers the amount of calcium the kidneys pass into urine and can slightly raise blood calcium, while vitamin D increases how much calcium the gut absorbs. In a 3-month trial in 328 Black adults given placebo or one of three daily amounts of vitamin D3, the 84 HCTZ users had slightly higher calcium than non-users, but only one developed high calcium (hypercalcemia). Higher vitamin D amounts than those tested, prescription active vitamin D, added calcium, or an undiagnosed parathyroid problem were not tested and may carry more risk.
atorvastatin + vitamin d
In a study of 16 patients on atorvastatin, vitamin D 800 IU a day for 6 weeks lowered atorvastatin blood levels, yet LDL cholesterol fell further (from 97 to 83 mg/dL) and total cholesterol fell from 169 to 157 mg/dL. Why atorvastatin levels fell is not settled; one proposed reason is that active vitamin D increases CYP3A4, the enzyme that breaks atorvastatin down. The study was small and not randomized.
boron + calcium
Boron is an ultratrace mineral that appears to reduce urinary calcium loss and to support the activity of vitamin D, which governs how much calcium the gut absorbs. In short-term feeding studies of postmenopausal women, adding boron lowered urinary calcium excretion and modestly raised estradiol. The effect is supportive rather than dramatic and is most relevant when boron intake from food is low.
probiotics + vitamin d
Vitamin D and probiotics act on overlapping pathways in the gut. Vitamin D supports vitamin D receptor (VDR) activity in the intestinal lining, which probiotics rely on for their anti-inflammatory and barrier-strengthening effects, while some probiotic strains appear to modestly raise circulating vitamin D. Randomized trials suggest combined supplementation can outperform either alone for some inflammatory and gut-barrier endpoints, though the evidence base is still limited.
fat-soluble vitamins + dietary fat
Vitamins A, D, E, and K depend on bile-driven micelle formation in the small intestine to be absorbed, and that process is triggered by dietary fat. Taking these vitamins with a fat-free meal or on an empty stomach reduces how much you absorb, while taking them with a meal that contains some fat improves absorption. Controlled studies in vitamin D show meaningfully greater absorption when the supplement is taken with fat.
phenytoin + vitamin d
Phenytoin induces the liver enzymes that break down vitamin D, accelerating clearance of 25-hydroxyvitamin D and lowering circulating levels over time. The downstream result can be reduced calcium absorption, a compensatory rise in parathyroid hormone, and an increased risk of softened bones (osteomalacia) and fractures with long-term use.
carbamazepine + vitamin d
Long-term carbamazepine use is linked to lower vitamin D. A meta-analysis of 12 studies found lower 25-hydroxyvitamin D in carbamazepine users than in controls, and an observational study found a pattern of bone markers suggestive of secondary hyperparathyroidism. The likely cause is faster breakdown of vitamin D by liver enzymes that carbamazepine switches on. The Tegretol label reports decreased blood calcium and osteoporosis.
vitamin d + parathyroid hormone test
Vitamin D supplementation genuinely lowers parathyroid hormone (PTH) by raising serum calcium and active vitamin D, so a PTH test drawn after recent vitamin D can read below the patient's true untreated baseline. This is a real physiologic effect and a timing/interpretation issue, not an assay artifact or a dangerous interaction.
